- year: 2018
  publications:
  - citation: "Qiao W, Martis S, Mendiratta G, Shi L, Botton MR, Yang Y, Gaedigk A, Vijzelaar R, Edelmann L, Kornreich R, Desnick RJ, Scott SA. Integrated CYP2D6 interrogation for multi-ethnic copy number and tandem allele detection. Pharmacogenomics. 2019;20:9-20. [Epub 2018 Dec 6]. "
  - citation: "Danese E, Raimondi S, Montagnana M,…, Scott SA,…, Pirmohamed M, Johnson JA, Fava C. The effect of CYP4F2, VKORC1 and CYP2C9 in influencing coumarin dose. A meta-analysis in more than 15,000 individuals. Clin Pharmacol Ther. [Epub 2018 Dec 2]. "
  - citation: "Yang JJ, Whirl-Carrillo M, Scott SA, Turner A, Schwab M, Tanaka Y, Suarez-Kurtz G, Schaeffeler E, Miller N, Klein TE, Gaedigk A. Pharmacogene Variation (PharmVar) Consortium gene introduction: NUDT15. Clin Pharmacol Ther. [Epub 2018 Dec 4]. "  
  - citation: "Thorn CF, Whirl-Carrillo M, Hachad H, Johnson JA, McDonagh EM, Ratain MJ, Relling MV, Scott SA, Altman RB, Klein TE. Essential characteristics of pharmacogenomics study publications. Clin Pharmacol Ther. 2019;105:86-91. [Epub 2018 Nov 8]. "  
  - citation: "Vijzelaar R, Botton MR, Stolk L, Martis S, Desnick RJ, Scott SA. Multi-ethnic SULT1A1 copy number profiling with multiplex ligation-dependent probe amplification. Pharmacogenomics. 2018;19:761-770. [Epub 2018 May 23]. "  
  - citation: "Hernandez-Suarez DF, Botton MR, Scott SA, Tomey MI, Garcia MJ, Wiley JM, Villablanca PA, Melin K, Lopez-Candales A, Renta JY, Duconge J. Pharmacogenetic association study on clopidogrel response among Puerto Rican Hispanics with cardiovascular disease. Pharmgenomics Pers Med. 2018;11:95-106. [Epub 2018 Jun 11.] "  
  - citation: "Roselli C, Chaffin MD, Weng LC, Aeschbacher S,…, Scott SA,…, Zeng L, Lubitz SA, Lunetta KL, Ellinor PT. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet. 2018;50:1225-1233 [Epub 2018 Jun 11.] "  
  - citation: "Pratt VM, Del Tredici A, Hachad H, Ji Y, Kalman L, Scott SA, Weck KE. Recommendations for Clinical CYP2C19 genotyping allele selection: A report of the Association for Molecular Pathology. J Mol Diagn. 2018;20:269-276. [Epub 2018 Feb 20.] "  
  - citation: "Hernandez-Suarez DF, Núñez-Medina H, Scott SA, Wiley JM, Garcia MJ, Melin K, Nieves-Borrero K, Rodriguez-Ruiz C, Lopez-Candales A, Marshall L, Duconge J. Effect of cilostazol on platelet reactivity among patients with peripheral artery disease on clopidogrel. Drug Metab Pers Ther. 2018;33:49-55. [Epub 2018 Feb 6.] "
  - citation: "Reiner J, Pisani L, Qiao W, Singh R, Yang Y, Shi L, Khan WA, Sebra R, Cohen N, Babu A, Edelmann L, Jabs EW, Scott SA. Cytogenomic identification and long-read single molecule real-time (SMRT) sequencing of a Bardet-Biedl Syndrome 9 (BBS9) deletion. npj Genomic Medicine. 2018;3:3. "
- year: 2017
  publications:
  - citation: "Scott SA, Owusu Obeng A, Botton MR, Yang Y, Scott ER, Ellis SB, Wallsten R, Kaszemacher T, Zhou X, Chen R, Nicoletti P, Naik H, Kenny EE, Vega A, Waite E, Diaz GA, Dudley J, Halperin JL, Edelmann L, Kasarskis A, Hulot J-S, Peter I, Bottinger EP, Hirschhorn K, Sklar P, Cho JH, Desnick RJ, Schadt EE. Institutional profile: Translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai. Pharmacogenomics. 2017;18:1381-1386. [Epub 2017 Oct 6.] "
  - citation: "Hernandez-Suarez DF, Scott SA, Tomey MI, Melin K, Lopez-Candales A, Buckley CE, Duconge J. Clinical determinants of clopidogrel responsiveness in a heterogeneous cohort of Caribbean Hispanics. Ther Adv Cardiovasc Dis. 2017;11:235-241. [Epub 2017 Jul 1.] "
  - citation: "Claudio-Campos K, Labastida A, Ramos A, Gaedigk A, Renta-Torres J, Padilla D, Rivera-Miranda G, Scott SA, Ruaño G, Cadilla CL, Duconge-Soler J. Warfarin anticoagulation therapy in Caribbean Hispanics of Puerto Rico: a candidate gene association study. Front Pharmacol. 2017;8:347. [Epub 2017 Jun 7.] "
  - citation: "Rasmussen-Torvik LJ, Almoguera B, Doheny KF, Freimuth RR, Gordon AS, Hakonarson H, Hawkins J, Ivacic L, Kullo IJ, Linderman MD, Manolio T, Owusu Obeng A, Pellegrino R, Prows CA, Pugh E, Ritchie MD, Smith M, Stallings SC, Wolf WA, Zhang K, Scott SA. Concordance between research sequencing and clinical pharmacogenetic genotyping in the eMERGE-PGx study. J Mol Diagn. 2017;19:561-566. [Epub 2017 May 11.] "
  - citation: "Yang Y&#42;, Botton MR&#42;, Scott ER, Scott SA. Sequencing the CYP2D6 gene: From variant allele discovery to clinical pharmacogenetic testing. Pharmacogenomics. 2017;18:673-685. [Epub 2017 May 4.] (&#42; equal contribution) "
  - citation: "Christophersen IE, Rienstra M, Roselli C, Yin X, Geelhoed B,…, Scott SA, …, Benjamin EJ, Tanaka T, Lunetta KL, Lubitz SL, Ellinor PT, on behalf of the AFGen Consortium. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet. 2017;49:946-952. [Epub 2017 Apr 17.] "
  - citation: "Nadkarni GN, Galarneau G, Ellis SB, Nadukuru R, Zhang J, Scott SA, Schurmann C, Li R, Rasmussen-Torvik LJ, Kho AN, Hayes MG, Pacheco JA, Manolio TA, Chisholm RL, Roden DM, Denny JC, Kenny EE, Bottinger EP. Association of Apolipoprotein L1 variants and blood pressure traits in African Americans. J Am Coll Cardiol. 2017;69:1564-1574. "
  - citation: "Karger L&#42;, Khan WA&#42;, Calabio R, Singh R, Xiang B, Babu A, Cohen N, Yang A, Scott SA. Maternal uniparental disomy of chromosome 15 and concomitant STRC and CATSPER2 deletion-mediated deafness-infertility syndrome. Am J Med Genet A. 2017;173:1436-1439. [Epub 2017 Mar 20.] (&#42; equal contribution) "
  - citation: "Reiner J, Karger L, Cohen N, Mehta L, Edelmann L, Scott SA. Chromosomal microarray detection of constitutional copy number variation using saliva DNA. J Mol Diagn. 2017;19:397-403. [Epub 2017 Mar 15.] "
  - citation: "Johnson JA, Caudle K, Gong L, Whirl-Carrillo M, Stein CM, Scott SA, Lee MT, Gage BF, Kimmel SE, Perera MA, Anderson JL, Pirmohamed M, Hines R, Klein TE, Limdi N, Cavallari LH, Wadelius M. Clinical Pharmacogenetics Implementation Consortium (CPIC®) guidelines for warfarin dosing: 2017 update. Clin Pharmacol Ther. 2017;102:397-404. [Epub 2017 Feb 15.] "
  - citation: "Stillitano F, Hansen J, Kong CW, Karakikes I, Funck-Brentano C, Scott SA, Reynier S, Ma W, Valogne Y, Desseaux C, Salem JE, Jeziorowska D, Zahr N, Li R, Ivengar R, Hajjar R, Hulot JS. Modeling susceptibility to drug-induced long QT with a panel of subject-specific iPS cells. eLife. 2017;6:e19406. "
- year: 2016
  publications:
  - citation: "Moriyama B, Owusu Obeng A, Barbarino JM, Penzak SR, Henning SA, Scott SA, Agúndez JAG, Wingard JR, McLeod HL, Klein TE, Cross S, Caudle KE, Walsh TJ. Clinical Pharmacogenetics Implementation Consortium (CPIC®) guideline for CYP2C19 and voriconazole dosing. Clin Pharmacol Ther. [Epub 2016 Dec 16.] "
  - citation: "Owusu Obeng A, Kaszemacher T, Abul-Husn NS, Gottesman O, Vega A, Waite E, Myers K, Cho J, Bottinger EP, Ellis SB, Scott SA. Implementing algorithm-guided warfarin dosing in an ethnically diverse patient population using electronic health records and pre-emptive CYP2C9 and VKORC1 genetic testing. Clin Pharmacol Ther. 2016;100:427-430. [Epub 2016 Jul 9.] "
  - citation: "Caudle KE, Dunnenburger HM, Freimuth RR, Peterson JF, Burlison JD, Whirl-Carrillo M, Scott SA, Rehm HL, Williams MS, Klein TE, Relling MV, Hoffman JM. Standardizing terms for clinical pharmacogenetic test results: The Clinical Pharmacogenetics Implementation Consortium (CPIC) term standardization project. Genet Med. 2017;19:215-223. [Epub 2016 Jul 21.] "  
  - citation: "Scott SA, Collet JP, Baber U, Yang Y, Peter I, Linderman M, Sload J, Qiao W, Kini AS, Sharma SK, Desnick RJ, Fuster V, Hajjar RJ, Montalescot G, Hulot JS. Exome Sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivity. Clin Pharmacol Ther. 2016;100:287-294. [Epub 2016 May 23.] "
  - citation: "Weisfeld-Adams JD, Tkachuk A, Maclean KN, Meeks N, Scott SA. A _de novo_ 2.78 Mb duplication on chromosome 21q22.11 implicates candidate genes in the partial trisomy 21 phenotype. npj Genomic Medicine. 2016;1:16003. "
  - citation: "Ruderfer DM, Charney AW, Readhead B, Kidd BA, Kähler AK, Kenny PJ, Keiser MJ, Moran JL, Hultman CM, Scott SA, Sullivan PF, Purcell SM, Dudley JT, Sklar P. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach. Lancet Psychiatry. 2016;3:350-357. [Epub 2016 Feb 22.] "
  - citation: "Bush WS, Crosslin DR, Owusu Obeng A, Wallace J, Almoguera B, Basford MA, Bielinski SJ, Carrell DS, Connolly JJ, Crawford D, Doheny KF, Gallego CJ, Gordon AS, Keating B, Kirby J, Kitchner T, Manzi S, Mejia AR, Pan V, Perry CL, Peterson JF, Prows CA, Ralston J, Scott SA, Scrol A, Smith M, Stallings SC, Veldhuizen T, Wolf W, Volpi S, Wiley K, Li R, Manolio T, Bottinger E, Brilliant MH, Carey D, Chisholm RL, Chute CG, Haines JL, Hakonarson H, Harley JB, Holm IA, Kullo IJ, Jarvik GP, Larson EB, McCarty CA, Williams MS, Denny JC, Rasmussen-Torvik LJ, Roden DM, Ritchie MD. Genetic variation among 82 pharmacogenes: The PGRN-Seq data from the eMERGE Network. Clin Pharmacol Ther. 2016;100:160-169. [Epub 2016 Feb 9.] "
  - citation: "Qiao W, Wang J, Pullman BS, Chen R, Yang Y, Scott SA. The CYP2D6 VCF translator. Pharmacogenomics J. 2017;17:301-303. [Epub 2016 Mar 15.] "
  - citation: "Zhang J&#42;, Fedick A&#42;, Wasserman S, Zhao G, Edelmann L, Bottinger EP, Kornreich R, Scott SA. Analytical validation of a personalized medicine APOL1 genotyping assay for non-diabetic chronic kidney disease risk assessment. J Mol Diagn. 2016;18:260-266. [Epub 2016 Jan 7.] (&#42; equal contribution) "
  - citation: "Van Driest SL, Wells QS, Stallings S, Bush WS, Gordon A, Nickerson DA, Kim JH, Crosslin DR, Jarvik GP, Carrell DS, Ralston JD, Larson EB, Bielinski SJ, Olson JE, Ye Z, Kullo IJ, Abul-Husn NS, Scott SA, Bottinger E, Almoguera B, Connolly J, Chiavacci R, Hakonarson H, Rasmussen-Torvik LJ, Pan V, Persell SD, Smith M, Chisholm RL, Kitchner TE, He MM, Brilliant MH, Wallace JR, Doheny KF, Shoemaker MB, Li R, Manolio TA, Callis TE, Macaya D, Williams MS, Carey D, Kapplinger JD, Ackerman MJ, Ritchie MD, Denny JC, Roden DM. Association of arrhythmia-related genetic variants with phenotypes documented in electronic medical records. JAMA. 2016;315:47-57. "
- year: 2015
  publications:
  - citation: "Qiao W&#42;, Yang Y&#42;, Sebra R, Mendiratta G, Gaedigk A, Desnick RJ, Scott SA. Long-read single-molecule real-time (SMRT) full gene sequencing of cytochrome P450-2D6 (CYP2D6). Hum Mut. 2016;37:315-323. [Epub 2015 Dec 18.] (&#42; equal contribution) "
  - citation: "Kalman LV, Agúndez JAG, Appell MLA, Black JL, Bell G, Boukouvala S, Bruckner C, Bruford E, Bruckner C, Caudle K, Coulthard S, Daly AK, Del Tredici AL, den Dunnen JT, Drozda K, Everts R, Flockhart D, Freimuth R, Gaedigk A, Hachad H, Hartshorne T, Ingelman-Sundberg M, Klein TE, Lauschke VM, Maglott DR, McLeod HL, McMillin GA, Meyer UA, Müller DJ, Nickerson DA, Oetting WS, Pacanowski M, Pratt VM, Relling MV, Roberts A, Rubinstein WS, Sangkuhl K, Schwab M, Scott SA, Sim SC, Thirumaran RK, Toji LH, Tyndale R, van Schaik RHN, Whirl-Carrillo M, Yeo K-TJ, Zanger UM. Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting. Clin Pharmacol Ther. 2016;99:172-185. [Epub 2015 Nov 20.] "
  - citation: "Pratt VM, Everts RE, Aggarwal P, Beyer BN, Broeckel U, Epstein-Baak R, Hujsak P, Kornreich R, Liao J, Lorier R, Scott SA, Smith CH, Toji LH, Turner A, Kalman LV. Characterization of 137 genomic DNA reference materials for 28 pharmacogenetic genes: A GeT-RM collaborative project. J Mol Diagn. 2016;18:109-123. [Epub 2015 Nov 24.] "
  - citation: "Yang Y, Lewis JP, Hulot JS, Scott SA. The pharmacogenetic control of antiplatelet response: Candidate genes and CYP2C19. Expert Opin Drug Metab Toxicol. 2015;11:1599-1617. [Epub 2015 Jul 14.] (Invited review) " 
  - citation: "Hicks JK, Bishop JR, Sangkuhl K, Müller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Klein TE, Caudle KE, Gaedigk A. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 2015;98:127-134. [Epub 2015 Jun 29.] "
  - citation: "Yang Y, Sebra R, Pullman B, Peter I, Desnick RJ, Geyer CR, DeCoteau JF, Scott SA. Quantitative and multiplexed DNA methylation analysis using long-read single-molecule real-time bisulfite sequencing (SMRT-BS). BMC Genomics. 2015;16:350. "
- year: 2014
  publications:
  - citation: "Termsarasab P, Yang AC, Reiner J, Mei H, Scott SA, Frucht SJ. Paroxysmal kinesigenic dyskinesia caused by 16p11.2 microdeletion. Tremor Other Hyperkinet Mov (N Y). 2014;4:274. "
  - citation: "Rasmussen-Torvik LJ, Stallings SC, Gordon AS, Almoguera B, Basford MA, Bielinski SJ, Brautbar A, Brilliant M, Carrell DS, Connolly J, Crosslin DR, Doheny KF, Gallego CJ, Gottesman O, Kim DS, Leppig KA, Li R, Lin S, Manzi S, Mejia AR, Pacheco JA, Pan V, Pathak J, Perry CL, Peterson JF, Prows CA, Ralston J, Rasmussen LV, Ritchie MD, Sadhasivam S, Scott SA, Smith M, Vega A, Vinks A, Volpi S, Wolf W, Bottinger E, Chisholm RL, Chute CG, Haines JL, Harley JB, Keating B, Holm IA, Kullo IJ, Jarvik GP, Larson EB, Manolio T, McCarty CA, Nickerson DA, Scherer SE, Williams MS, Roden DM, Denny JC. Design and anticipated outcomes of the eMERGE-PGx project: A multi-center pilot for pre-emptive pharmacogenomics in electronic health record systems. Clin Pharmacol Ther. 2014;96:482-489. [Epub 2014 Jun 24.] "
  - citation: "Abul-Husn NS&#42;, Owusu Obeng A&#42;, Sanderson SC, Gottesman O, Scott SA. Implementation and utilization of genetic testing in personalized medicine. Pharmgenomics Pers Med. 2014;7:227-240. (&#42; equal contribution) (Invited review) "
  - citation: "Jaja C, Patel N, Scott SA, Gibson R, Kutlar A. CYP2C9 allelic variants and frequencies in pediatric sickle cell disease cohort: Implications for NSAIDs pharmacotherapy. Clin Transl Sci. 2014;7:396-401. [Epub 2014 May 29.] "
  - citation: "Yang Y, Peter I, Scott SA. Pharmacogenetics in Jewish populations. Drug Metabol Drug Interact. 2014;29:221-233. [Epub May 27 2014] (Invited review) "
  - citation: "Overby CL, Ludtke A, Abul-Husn NS, Ellis S, Scott SA, Owusu Obeng A, Kannry JL, Hripcsak G, Bottinger EP, Gottesman O. Physician attitudes toward adopting genome-guided prescribing through clinical decision support. J Pers Med. 2014;4:35-49. "
  - citation: "Scott SA and Lubitz SA. Warfarin pharmacogenetic trials: Is there a future for pharmacogenetic-guided dosing? Pharmacogenomics. 2014;15:719-722. (Invited editorial) "
  - citation: "Scott SA, Owusu Obeng A, Hulot JS. Antiplatelet drug interactions with proton pump inhibitors. Expert Opin Drug Metab Toxicol. 2014;10:175-189. [Epub 2013 Nov 9.] (Invited review) "
  - citation: "Caudle KE, Klein TE, Hoffman JM, Müller DJ, Whirl-Carrillo M, McDonagh EM, Sangkuhl K, Thorn CF, Schwab M, Agúndez JAG, Freimuth RR, Huser V, Lee MTM, Iwuchukwu OF, Crews KR, Scott SA, Wadelius M, Swen JJ, Tyndale RF, Stein CM, Roden D, Relling MV, Williams MS, Johnson SG. Incorporation of pharmacogenomics into routine clinical practice: The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr Drug Metab. 2014;15:209-217. [Epub 2014 Jan 30.] "
- year: 2013
  publications:
  - citation: "Kadian-Dodov D, van der Zee S, Scott SA, Peter I, Martis S, Doheny DO, Rothlauf EB, Lubitz SA, Desnick RJ, Halperin JH. Warfarin pharmacogenetics: A controlled dose response study in healthy subjects. Vasc Med. 2013;18:290-297. [Epub 2013 Sep 12.] "
  - citation: "Scott SA, Tan Q, Baber U, Martis S, Yang Y, Bander J, Kornreich R, Hulot J-S, Desnick RJ. An allele-specific PCR system for rapid detection and discrimination of the CYP2C19&#42;4A, &#42;4B, and &#42;17 alleles: Implications for clopidogrel response testing. J Mol Diagn. 2013;15:783-789. [Epub 2013 Sep 4.] "
  - citation: "Scott SA, Sangkuhl K, Stein CM, Hulot J-S, Mega JL, Roden DM, Klein TE, Sabatine MS, Johnson JA, Shuldiner AR. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy: 2013 Update. Clin Pharmacol Ther, 2013;94:317-323. [Epub 2013 May 22.] "
  - citation: "Luo M, Liu L, Peter I, Scott SA, Eversley C, Kornreich R, Desnick RJ, Edelmann L. Spinal muscular atrophy: Improved detection of silent (2+0) carriers by identification of SMN1 founder alleles. Genet Med. 2014;16:149-156. [Epub 2013 Jun 20.] "
  - citation: "Baber U, Bander J, Karajgikar R, Abraham B, Yadav K, Hadi A, Theodoropolous K, Gukathasan N, Thapi R, Roy S, Sayeneni S, Scott SA, Palkhiwala S, Suleman J, Kovacic J, Yu J, Sartori S, Dangas G, Mehran R, Uribarri J, Badimon J, Muntner P, Moreno P, Kini AS, Sharma SK. Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity. Thromb Haemost, 2013;110:118-123. [Epub 2013 May 16.] "
  - citation: "Gottesman O, Scott SA, Ellis SB, Overby CL, Ludtke A, Hulot J-S, Hall J, Chatani K, Myers K, Kannry JL, Bottinger EP. The CLIPMERGE PGx Program: Clinical Implementation of Personalized Medicine through Electronic Health Records and Genomics - Pharmacogenomics. Clin Pharmacol Ther. 2013;94:214-217. [Epub 2013 Apr 3.] "
  - citation: "Perera MA, Cavallari LH, Limdi NA, Gamazon ER, Konkashbaev A, Daneshjou R, Pluzhnikov A, Crawford DC, Wang J, Liu N, Tatonetti NJ, Bourgeois S, Takahashi H, Bradford Y, Burkley BM, Desnick RJ, Halperin JL, Khalifa SI, Langaee TY, Lubitz SA, Nutescu EA, Oetjens M, Shahin MH, Shitalben RP, Tector M, Rieder MJ, Scott SA, Wu AHB, Burmester JK, Deloukis P, Wagner MJ, Mushiroda T, Kubo M, Roden DM, Cox NJ, Altman RB, Klein TE, Nakamura Y, Johnson JA. Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. Lancet. 2013;382:790-796. [Epub 2013 Jun 4.] "
  - citation: "Scott SA&#42;, Liu B&#42;, Nazarenko I&#42;, Martis S, Kozlitina J, Yang Y, Ramirez C, Kasai Y, Hyatt T, Peter I, Desnick RJ. Frequency of the Cholesteryl Ester Storage Disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups. Hepatology. 2013;58:958-965. [Epub 2013 Feb 19.] (&#42; equal contribution) "
  - citation: "Scott SA. Clinical pharmacogenomics: Opportunities and challenges at point-of-care. Clin Pharmacol Ther. 2013;93:33-35. [Epub 2012 Dec 5.] (Invited manuscript)"
  - citation: "Martis S, Mei H, Vijzelaar R, Edelmann L, Desnick RJ, Scott SA. Multi-ethnic cytochrome-P450 copy number profiling: novel pharmacogenetic alleles and mechanism of copy number variation formation. Pharmacogenomics J. 2013;13:558-566. [Epub 2012 Nov 20.] "
- year: 2012
  publications:
  - citation: "Danese E, Montagnana M, Johnson JA, Rettie A, Zambon CF, Lubitz SA, Suarez-Kurtz G, Cavallari LH, Zhao L, Huang M, Nakamura Y, Mushiroda T, Kringen MK, Borgiani P, Ciccacci C, Rieder MJ, Langaee TJ, Siguret V, Loriot MA, Sagreiya H, Altman RB, Shahin MHA, Scott SA, Khalifa SI, Chowbay B, Suriapranata IM, Teichert M, Taljaard M, Botton MR, Zhang JE, Pirmohamed M, Zhang X, Carlquist JF, Horne BD, Lee MTA, Pengo V, Guidi GC, Minuz P, Fava C. Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: a systematic review and meta-analysis. Clin Pharmacol Ther. 2012;92:746-756. "
  - citation: "Lyon E, Foster JG, Palomaki GE, Pratt VM, Reynolds K, Sabato F, Scott SA, Vitaska P. A working group of the Molecular Genetics Subcommittee on behalf of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee. Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy. Genet Med. 2012;14:990-1000. [Epub 2012 Sept 6.] "
  - citation: "Takahashi N, Miura M, Scott SA, Niioka T, Sawada K. Pharmacokinetics of dasatinib for Philadelphia chromosome-positive acute lymphocytic leukemia with acquired T315I mutation. J Hematol Oncol. 2012;5:23. "
  - citation: "Martis S, Peter I, Hulot J-S, Kornreich R, Desnick RJ, Scott SA. Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes. Pharmacogenomics J. 2013;13:369-377. [Epub 2012 Apr 10.] "
  - citation: "Scott SA&#42;, Patel M&#42;, Martis S, Lubitz SA, van Der Zee S, Edelmann L, Yoo C, Halperin JL, Desnick RJ. Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX, and CALU. Pharmacogenomics. 2012;13:297-307. [Epub 2011 Dec 21.] (&#42; equal contribution) "
  - citation: "Scott SA. Personalizing medicine with clinical pharmacogenetics. Genet Med. 2011;13:987-995. (Invited review) "
  - citation: "Cayla G, Hulot J-S, O’Connor S, Pathack A, Scott SA, Gruel Y, Silvain J, Vignalou JB, Huerre Y, de la Briolle A, Allanic F, Beygui F, Barthelemy O, Montalescot G, Collet JP. Clinical, angiographic and genetic determinants of early coronary stent thrombosis: the ONASSIST study. JAMA. 2011;306:1765-1774. "
  - citation: "Scott SA, Sangkuhl K, Shuldiner AR, Hulot J-S, Thorn CF, Altman RB, Klein TE. PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19 (CYP2C19). Pharmacogenet Genomics. 2012;22:159-165. [Epub 2011 Oct 24.] "
- year: 2011
  publications:
  - citation: "Hulot JS, Collet JP, Cayla G, Silvain J, Allanic F, Bellemain-Appaix A, Scott SA, Montalescot G. CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics and clinical efficacy in post-myocardial infarction patients. Circ Cardiovasc Interv. 2011;4:422-428. "
  - citation: "Johnson JA, Gong L, Carrillo M, Gage BF, Scott SA, Stein CM, Anderson JL, Kimmel SE, Lee MT, Pirmohamed M, Wadelius M, Klein TE, Altman RB. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther. 2011;90:625-629. "
  - citation: "Varricchio L, Goldbold J, Scott SA, Whitsett C, Da Costa L, Pospisilova D, Garelli E, Quarello P, Ramenghi U, Migliaccio AR. Increased frequency of the glucocorticoid receptor A3669G (rs6198) polymorphism in patients with Diamond-Blackfan Anemia. Blood. 2011;118:473-474. "
  - citation: "Scott SA, Sangkuhl K, Gardner EE, Stein CM, Hulot J-S, Johnson JA, Roden DM, Klein TE, Shuldiner AR. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy. Clin Pharmacol Ther. 2011;90:328-332. "
  - citation: "Scott SA, Martis S, Peter I, Kasai Y, Kornreich R, Desnick RJ. Identification of CYP2C19&#42;4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness. Pharmacogenomics J. 2012;12:297-350. [Epub 2011 Mar 1.] "
- year: 2010
  publications:
  - citation: "Takahashi N, Wakita H, Miura M, Scott SA, Nishii K, Masuko M, Sakai M, Maeda Y, Ishige K, Kashimura M, Fujikawa K, Fukazawa M, Katayama T, Monna F, Narita M, Katayama N, Furukawa T, Miyazaki Y, Urase F, Sawada K. Correlation of imatinib pharmacokinetics with clinical response in Japanese patients with chronic phase chronic myeloid leukemia. Clin Pharmacol Ther. 2010;88:809-813. "
  - citation: "Takahashi N, Miura M, Scott SA, Kagaya H, Kameoka Y, Tagawa H, Fujishima N, Saito H, Yoshioka T, Hirokawa M, Sawada K. Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic-phase chronic myeloid leukemia. J Hum Genet. 2010;55:731-737. "
  - citation: "Scott SA, Edelmann L, Liu L, Luo M, Desnick RJ, Kornreich R. Experience with carrier screening and prenatal diagnosis for sixteen Ashkenazi Jewish genetic diseases. Hum Mut. 2010;31:1240-1250. "
  - citation: "Scott SA&#42;, Cohen N&#42;, Brandt T, Warburton PE, Edelmann L. Large inverted repeats within Xp11.2 are present at the breakpoints of isodicentric X chromosomes in Turner syndrome. Hum Mol Genet. 2010;19:3383-3393. (&#42; equal contribution) "
  - citation: "Scott SA, Khasawneh R, Peter I, Kornreich R, Desnick RJ. Combined CYP2C9, VKORC1, and CYP4F2 allele frequencies among racial and ethnic groups. Pharmacogenomics. 2010;11:781-791. "
  - citation: "Lubitz SA&#42;, Scott SA&#42;, Rothlauf E, Agarwal A, Peter I, Doheny D, van Der Zee S, Jaremko M, Desnick RJ, Halperin JL. Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population. J Thromb Haemost. 2010;8:1018-1026. (&#42; equal contribution)"
  - citation: "Scott SA, Cohen N, Brandt T, Desnick RJ, Toruner G, Edelmann L. Detection of low-level mosaicism and placental mosaicism by oligonucleotide array comparative genomic hybridization. Genet Med. 2010;12:85-92. "
  - citation: "Lakshmikuttyamma A, Scott SA, DeCoteau JF, Geyer CR. Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition. Oncogene. 2010;29:576-588. "
- year: PRE-2010
  publications:
  - citation: "Scott SA, Jaremko M, Lubitz SA, Kornreich R, Halperin JL, Desnick RJ. CYP2C9&#42;8 is prevalent among African-Americans: implications for pharmacogenetic dosing. Pharmacogenomics. 2009;10:1243-1255. "
  - citation: "Takahashi N, Kameoka Y, Yamanaka Y, Ubukawa K, Saito K, Fujishima M, Fujishima N, Saito H, Hirokawa M, Scott SA, Sawada K. Itraconazole oral solution enhanced vincristine neurotoxicity in five patients with malignant lymphoma. Intern Med. 2008;47:651-653. "
  - citation: "Yu WP, Scott SA, Dong WF. Induction of ID1 expression and apoptosis by the histone deacetylase inhibitor (trichostatin A) in human acute myeloid leukaemic cells. Cell Prolif. 2008;41:86-97. "
  - citation: "Scott SA, Edelmann L, Kornreich R, Desnick RJ. Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations. Am J Hum Genet. 2008;82:495-500. "
  - citation: "Scott SA, Edelmann L, Kornreich R, Erazo M, Desnick RJ. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population. Pharmacogenomics. 2007;8:721-730. "
  - citation: "Scott SA, Lakshimikuttysamma A, Sheridan DP, Sanche SE, Geyer CR, DeCoteau JF. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with demethylation and reexpression of p15INK4B. Exp Hematol. 2007;35:263-273. "
  - citation: "Scott SA&#42;, Dong W&#42;, Ichinohasama R, Hirsch C, Sheridan D, Sanche S, Geyer CR, DeCoteau JF. 5-aza-2’-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation. Leuk Res. 2006;30:69-76. (&#42; equal contribution) "
  - citation: "Scott SA&#42;, Kimura T&#42;, Dong WF, Ichinohasama R, Bergen S, Kerviche A, Sheridan D, DeCoteau JF. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia. Leuk Res. 2004;28:1293-1301. (&#42; equal contribution) "
  - citation: "Scott SA, Kimura T, Ichinohasama R, Bergen S, Magliocco A, Reimer C, Kerviche A, Sheridan D, DeCoteau JF. Microsatellite mutations of Transforming growth factor- receptor type II and Caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter hypermethylation. Leuk Res. 2003;27:23-34. "
  - citation: "Lowsky R, Magliocco A, Ichinohasama R, Reitmair A, Scott SA, Henry M, Kadin ME, DeCoteau JF. MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability. Blood. 2000;95:1767-1772. "
- year: Collaborator Manuscripts
  publications:
  - citation: "Gaedigk A, Sangkuhl K, Whirl-Carrillo M, Twist GP, Klein TE, Miller NA; **PharmVar Steering Committee**. The Evolution of PharmVar. Clin Pharmacol Ther. [Epub 2018 Dec 7] "
  - citation: "Gaedigk A, Ingelman-Sundberg M, Miller NA, Leeder JS, Whirl-Carrillo M, Klein TE; **PharmVar Steering Committee**. The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database. Clin Pharmacol Ther. 2018;103:399-401. [Epub 2017 Nov 14] "
  - citation: "Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, Ledbetter DH, Maglott DR, Martin CL, Nussbaum RL, Plon SE, Ramos EM, Sherry ST, Watson MS; **ClinGen**. ClinGen--the Clinical Genome Resource. N Engl J Med. 2015;372:2235-42. "
  - citation: "Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA 3rd, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH; **COAG Investigators**. A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med. 2013;369:2283-2293. [Epub 2013 Nov 19.] "
  - citation: "Gottesman O, Kuivaniemi H, Tromp G, Faucett WA, Li R, Manolio TA, Sanderson SC, Kannry J, Zinberg R, Basford MA, Brilliant M, Carey DJ, Chisholm RL, Chute CG, Connolly JJ, Crosslin D, Denny JC, Gallego CJ, Haines JL, Hakonarson H, Harley J, Jarvik GP, Kohane I, Kullo IJ, Larson EB, McCarty C, Ritchie MD, Roden DM, Smith ME, Böttinger EP, Williams MS; **eMERGE Network**. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med. 2013;15:761-771. [Epub 2013 Jun 6.] "
- year: Book Chapters
  publications:
  - citation: "Owusu Obeng A, Samwald M, Scott SA. Reactive, point-of-care, pre-emptive and direct-to-consumer pharmacogenomic testing. In: [Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, 2nd Edition.](https://www.elsevier.com/books/pharmacogenomics/lam/978-0-12-812626-4) Lam YWF and Scott SA, eds. Elsevier, New York, NY. pp. 369-384, 2018 "
  - citation: "Botton MR, Campos KC, Duconge J, Scott SA. Pharmacogenomics in Latin American populations. In: [Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, 2nd Edition.](https://www.elsevier.com/books/pharmacogenomics/lam/978-0-12-812626-4) Lam YWF and Scott SA, eds. Elsevier, New York, NY. pp. 329-368, 2018. "
  - citation: "Lam YWF, Scott SA. Pharmacogenomics in cancer therapeutics. In: [Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, 2nd Edition.](https://www.elsevier.com/books/pharmacogenomics/lam/978-0-12-812626-4) Lam YWF and Scott SA, eds. Elsevier, New York, NY. pp. 123-132, 2018. "
  - citation: "Yang Y, Scott SA. DNA Methylation profiling using long-read single-molecule real-time bisulfite sequencing (SMRT-BS). In: Functional Genomics, 3rd Edition. Methods Mol Biol; 1654. Kaufmann M, Klinger C, Savelsbergh A, eds. Springer, New York, NY. pp. 125-134, 2017. "
  - citation: "Pratt VM, Scott SA. Personalized medicine in cancer treatment. In: Diagnostic Molecular Pathology. Coleman WB, and Tsongalis G, eds. Academic Press, New York, NY. pp. 503-513, 2016. "
  - citation: "Obeng AO, Scott SA. Pharmacogenetics of antiplatelet drugs. In: Pharmacogenomics: Applications to Patient Care, 3rd Edition. Johnson JA, Ellingrod V, Kroetz D, and Kuo G, eds. American College of Clinical Pharmacy, Lenexa, KS. pp. 65-78, 2014. "
  - citation: "Scott SA, Lyon E. Pharmacogenetics. In: Molecular Pathology in Clinical Practice, 2nd Edition. Leonard DGB, ed. Springer Publishing Company, New York, NY. pp. 301-312, 2016. "
  - citation: "Scott SA. Implementing clinical pharmacogenetics: Point-of-care and pre-emptive testing. In: Handbook of Pharmacogenomics and Stratified Medicines. Padmanabdhan S, ed. Elsevier, Oxford, UK. pp. 921-929, 2014. "
  - citation: "Scott SA, Desnick RJ. Pharmacogenetics of warfarin. In: Clinical Genomics: Practical Applications in Adult Patient Care. Murray MF, Giovanni MA, and Babyatsky M, eds. McGraw Hill Publishers, Columbus, OH. pp. 24-29, 2013. "
  - citation: "Edelmann L, Scott SA, Liu L, Kornreich R. Molecular medical genetics. In: Molecular Genetic Pathology, 1st and 2nd Editions. Cheng L and Zhang D, eds. Humana Press Inc., Totowa, NJ, pp. 415-440, 2008. "
- year: Popular and Scientific Press Commentary
  publications:
  - citation: "**10/15/2017:** Copy Number Variation Probes Inform Diverse Applications. Richard A. Stein; **GEN News**, [https://www.genengnews.com/gen-articles/copy-number-variation-probes-inform-diverse-applications/6178](https://www.genengnews.com/gen-articles/copy-number-variation-probes-inform-diverse-applications/6178). "
  - citation: "**10/11/2016:** Long-Read CYP2D6 Sequencing Enables Full Gene Characterization and Novel Allele Discovery. Stuart A. Scott, Ph.D. and Yao Yang, Ph.D.; **Drug Discovery & Development**, [http://www.dddmag.com/article/2016/10/long-read-cyp2d6-sequencing-enables-full-gene-characterization-and-novel-allele-discovery](http://www.dddmag.com/article/2016/10/long-read-cyp2d6-sequencing-enables-full-gene-characterization-and-novel-allele-discovery). "
  - citation: "**9/26/2016:** Researchers Hope PharmCAT Tool Will Help Improve Clinical Implementation of Pharmacogenomics. Julia Karow; **GenomeWeb**, [https://www.genomeweb.com/molecular-diagnostics/researchers-hope-pharmcat-tool-will-help-improve-clinical-implementation](https://www.genomeweb.com/molecular-diagnostics/researchers-hope-pharmcat-tool-will-help-improve-clinical-implementation). "
  - citation: "**9/8/2016:** Pharmacogenetics: The Right Drug for You. Liam Drew; **Nature**, 537, S60–S62 (08 September 2016) [doi:10.1038/537S60a0](http://www.nature.com/nature/journal/v537/n7619_supp/full/537S60a.html?WT.mc_id=TWT_OUTLOOK_PRECISIONMEDICINE). "
  - citation: "**9/1/2016:** Pharmacogenetics Informs Clinical Practice. DeeAnn Visk, Ph.D.; **GEN News**, [http://www.genengnews.com/gen-articles/pharmacogenetics-informs-clinical-practice/5816/](http://www.genengnews.com/gen-articles/pharmacogenetics-informs-clinical-practice/5816/). "
  - citation: "**6/15/2016:** Determining a Drug Response. Sonya Collins; **Genome Magazine**, [http://genomemag.com/pharmacogenomics/#.V5NbPY4pOt8](http://genomemag.com/pharmacogenomics/#.V5NbPY4pOt8). "
  - citation: "**3/19/2015:** The Right Drug the First Time. Aaron Krol; **Bio-IT World & Clinical Informatics News**, [http://www.bio-itworld.com/2015/3/19/right-drug-first-time.html](http://www.bio-itworld.com/2015/3/19/right-drug-first-time.html). "
  - citation: "**3/5/2015:** Copy Number Variations’ Effect on Drug Response Still Overlooked. Cassandra Willyard; **Nature Medicine**, 21, 206 (2015) [doi:10.1038/nm0315-206](http://www.nature.com/nm/journal/v21/n3/full/nm0315-206.html). "
  - citation: "**3/12/2013:** Mount Sinai Group Publishes Allele-Specific PCR Assay for Novel CYP2C19 Variants. Ben Butkus; **GenomeWeb**, [https://www.genomeweb.com/pcrsample-prep/mount-sinai-group-publishes-allele-specific-pcr-assay-novel-cyp2c19-variants](https://www.genomeweb.com/pcrsample-prep/mount-sinai-group-publishes-allele-specific-pcr-assay-novel-cyp2c19-variants). "
  - citation: "**8/15/2012:** Without Tests, Heart Drug May Not Work. Elie Dolgin; **The Jewish Daily FORWARD**, [http://forward.com/articles/160778/without-tests-heart-drug-may-not-work/](http://forward.com/articles/160778/without-tests-heart-drug-may-not-work/). "
